Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa.
about
Mechanisms leading to in vivo ceftolozane/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Mechanisms leading to in vivo ...... by MDR Pseudomonas aeruginosa.
@en
Mechanisms leading to in vivo ...... by MDR Pseudomonas aeruginosa.
@nl
type
label
Mechanisms leading to in vivo ...... by MDR Pseudomonas aeruginosa.
@en
Mechanisms leading to in vivo ...... by MDR Pseudomonas aeruginosa.
@nl
prefLabel
Mechanisms leading to in vivo ...... by MDR Pseudomonas aeruginosa.
@en
Mechanisms leading to in vivo ...... by MDR Pseudomonas aeruginosa.
@nl
P2093
P2860
P356
P1476
Mechanisms leading to in vivo ...... by MDR Pseudomonas aeruginosa
@en
P2093
Antonio Oliver
Gabriel Cabot
José L Pérez
Leonor Periañez
M Luisa Martín-Pena
Pablo A Fraile-Ribot
Xavier Mulet
P2860
P304
P356
10.1093/JAC/DKX424
P407
P50
P577
2018-03-01T00:00:00Z